Artiklar
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?
(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).
Uncovering the Hidden Burden: Understanding Loss of Smell in CRSwNP
Navigating the Complexities of Smell Loss in Patients with CRSwNP.
The Long-Term Impact of Early-Onset Atopic Dermatitis
A recent study led by professor Jonathan Silverberg involving over 30,000 participants has highlighted the significant psychosocial burden faced by adults with early-onset atopic dermatitis (AD). Learn more and continue reading.
Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.
Global Developments in Early Detection of Autoimmune Type 1 Diabetes
Curious about the characteristics of pre-symptomatic- and stage 3 Type 1 Diabetes? Interested in learning about the potential benefits of screening for autoimmune Type 1 Diabetes?
This short film gives you an overview of recent developments in diagnosis of Type 1 Diabetes, showcasing how early detection efforts can benefit those who need it the most.
2024 ESC Guidelines for the management of chronic coronary syndromes
Felicita Andreotti, Italy; Christiaan J M Vrints, Belgium
En minut för att sprida ljus över nya möjligheter inom KOL
Att förstå typ 2-inflammation* kan hjälpa till att belysa varför vissa patienter fortsätter att få exacerbationer. Titta på denna video för att lära dig hur.1
SE-FILMEN-HÄR
